Blog

As discussed in previous blog articles, early planning is critical, both for cell therapy clinical trials and commercial-scale operations. By addressing how activities will be managed early on, it can minimize risk and cost, and optimize downstream processes. However, oftentimes clients are unsure of which components are critical to address early on.

By : Moronke Iyoha
on Aug 16, 2017 10:00:10 AM

Personalized Medicine and Validation of Next-Generation Sequencing

Personalized medicine and next-generation sequencing (NGS) are two trends producing major swings in the healthcare industry. As previously discussed on Doe & Ingalls blog, here are some points you should be familiar with if your strategy touches upon either of these.

By : Eugene Kang
on Apr 19, 2016 11:00:00 AM

Topic: Qualification / Validation, Topic: Laborato..........

Blog

Importance of Early Planning for Cell Therapy Clinical Trials

Recommend Reading:

Select Topics

Select Author

Select Content

Personalized Medicine and Validation of Next-Generation Sequencing

Blog

Importance of Early Planning for Cell Therapy Clinical Trials

Subscribe to Email Updates

Recommend Reading:

Select Topics

Select Author

Select Content

Personalized Medicine and Validation of Next-Generation Sequencing